In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Novartis AG (NOVN – Research Report), with a price ...
For years, social media users have shared what they describe as Netflix's original logo featuring black lettering and a ...
The 1/1 licensing model means that Emblème is unique to one brand, making it kind of like the NFT of the typography world.
The first Microsoft logo featured a stylised ‘Micro-Soft' in a funky 1970s-esque font, encapsulating the spirit of the emerging software industry. In 1987, the logo was updated to incorporate the ...
According to iSpot.TV’s analysis of January TV drug ad spending data, Novartis’ prostate cancer drug Pluvicto swooped in to take the No. 1 spot on the list, with more than $47 million spent ...
OpenAI has finally unveiled its first major rebrand, with a similar but new logo, a new typeface, and colour palette. This change aims to create a more organic and more human brand identity, according ...
Novartis (NVS) CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if its main focus remains on therapeutic areas where it ...
10 luxury brand logos have mastered it. They've become more than marks on products—they're cultural touchstones, over decades and continents. Logos are stories we tell ourselves. The best ones?
But Steinfeld is gearing up for another arena. Steinfeld is teaming up with pharmaceutical company Novartis to raise awareness about breast cancer with a bold and empowering commercial that will ...
Empowering All Women to Own Their Breast Health "Novartis has been raising the bar in breast cancer care for the past 30+ years, most recently advancing a new treatment option for the broadest ...
To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s biggest stages. The drugmaker’s first-ever Super Bowl ad is set to ...
Existing investor F-Prime Capital also joined the round, with participation from new investors Novartis Venture Fund, RiverVest Venture Partners, funds managed by abrdn, Pictet Alternative ...